Zhenli Zhang

Title: Zhenli Zhang: Innovator in Diabetes Treatment

Introduction

Zhenli Zhang is a prominent inventor based in Beijing, China. He has made significant contributions to the field of biotechnology, particularly in the treatment of metabolic diseases such as diabetes. With a total of two patents to his name, Zhang is recognized for his innovative approaches to medical treatments.

Latest Patents

Zhenli Zhang's latest patents focus on the development of a method for treating diabetes using FGF21 and GLP1 double gene-modified cells. These patents provide a modified mesenchymal stem cell and its culture supernatant, along with a pharmaceutical composition that includes these components. The mesenchymal stem cell is designed to express a first protein selected from FGF21 or its variants, and a second protein selected from GLP-1 or its variants. This innovative approach aims to enhance the treatment of metabolic diseases and facilitate the preparation of medicaments for such conditions.

Career Highlights

Zhenli Zhang is associated with Beijing Jiyuan Biological Technology Co., Ltd., where he continues to advance his research and development efforts. His work is pivotal in the ongoing quest to find effective treatments for diabetes and other metabolic disorders. Zhang's contributions are not only significant in terms of patents but also in the potential impact on patient care and treatment outcomes.

Collaborations

Zhenli Zhang collaborates with notable colleagues, including Haifeng Duan and Binghua Xue. Their combined expertise enhances the research and development efforts at their company, fostering innovation in the field of biotechnology.

Conclusion

Zhenli Zhang stands out as an influential inventor in the realm of diabetes treatment, with his innovative patents paving the way for new therapeutic options. His work exemplifies the critical role of inventors in advancing medical science and improving health outcomes.